These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9543585)

  • 1. Tamoxifen-induced regression of breast cysts.
    Hurst JL; Mega JF; Hogg JP
    Clin Imaging; 1998; 22(2):95-8. PubMed ID: 9543585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of follow-up mammography in estimating the effect of tamoxifen in breast cancer patients who have undergone surgery.
    Son HJ; Oh KK
    AJR Am J Roentgenol; 1999 Oct; 173(4):905-9. PubMed ID: 10511146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.
    Cohen I; Figer A; Tepper R; Shapira J; Altaras MM; Yigael D; Beyth Y
    Gynecol Oncol; 1999 Feb; 72(2):202-7. PubMed ID: 10021302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of long-term tamoxifen therapy on the occurrence of contralateral primary breast cancer].
    Xing B; Huang X; Wang Y
    Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):143-5. PubMed ID: 9206051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.
    Alkner S; Bendahl PO; Fernö M; Nordenskjöld B; Rydén L;
    Eur J Cancer; 2009 Sep; 45(14):2496-502. PubMed ID: 19535242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cysts in tamoxifen-treated women with breast cancer.
    Inal MM; Incebiyik A; Sanci M; Yildirim Y; Polat M; Pilanci B; Nayki C; Camuzcuoğlu H
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):104-6. PubMed ID: 15866095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The control of breast cancer: the role of tamoxifen.
    Forbes JF
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-5-S1-19. PubMed ID: 9045316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant mixed Müllerian tumor of the uterus associated with tamoxifen therapy for breast cancer.
    Magnani KK; Dubey S; Rai S
    Indian J Pathol Microbiol; 2010; 53(4):886-7. PubMed ID: 21045469
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging.
    King V; Kaplan J; Pike MC; Liberman L; David Dershaw D; Lee CH; Brooks JD; Morris EA
    Breast J; 2012; 18(6):527-34. PubMed ID: 23002953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen-induced fatty liver in patients with breast cancer.
    Ogawa Y; Murata Y; Nishioka A; Inomata T; Yoshida S
    Lancet; 1998 Mar; 351(9104):725. PubMed ID: 9504521
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic approach to ovarian cysts in tamoxifen-treated women with breast cancer.
    Shushan A; Peretz T; Mor-Yosef S
    Int J Gynaecol Obstet; 1996 Mar; 52(3):249-53. PubMed ID: 8775677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonographic evaluation of endometrial disease in postmenopausal patients with breast cancer and tamoxifen treatment.
    Cohen I; Tepper R; Beyth Y
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):252. PubMed ID: 9914614
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgery for early and minimally invasive breast cancer.
    Graves TA; Bland KI
    Curr Opin Oncol; 1996 Nov; 8(6):468-77. PubMed ID: 8971466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can mammographic densities predict effects of tamoxifen on the breast?
    Ursin G; Pike MC; Spicer DV; Porrath SA; Reitherman RW
    J Natl Cancer Inst; 1996 Jan; 88(2):128-9. PubMed ID: 8537975
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen in women with breast cancer and mammographic density.
    Meggiorini ML; Labi L; Vestri AR; Porfiri LM; Savelli S; De Felice C
    Eur J Gynaecol Oncol; 2008; 29(6):598-601. PubMed ID: 19115686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does hormonal therapy decrease tamoxifen associated hot flashes?
    Barton DL; Loprinzi CL
    Breast Cancer Res Treat; 2009 Aug; 116(3):529-30. PubMed ID: 19205876
    [No Abstract]   [Full Text] [Related]  

  • 18. Tamoxifen added to adjuvant chemotherapy in premenopausal women with early breast cancer: is it standard practice or still a subject for study?
    Bramwell VH; Pritchard KI
    Eur J Cancer; 1999 Nov; 35(12):1625-7. PubMed ID: 10674005
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical efficacy of tamoxifen.
    Robert NJ
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):15-20. PubMed ID: 9065922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.
    Mullooly M; Pfeiffer RM; Nyante SJ; Heckman-Stoddard BM; Perloff M; Jatoi I; Brinton LA; Aiello Bowles EJ; Hoover RN; Glass A; Berrington de Gonzalez A; Sherman ME; Gierach GL
    J Clin Oncol; 2016 Jun; 34(18):2093-7. PubMed ID: 27022110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.